Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Yip

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2015
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17S Y Brulé, D J Jonker, C S Karapetis, et al.
Internal Medicine Journal|July 10, 2013
Developing a national database for metastatic colorectal cancer management: perspectives and challengesK Field, H-L Wong, J Shapiro, et al.
Scientific Reports|December 6, 2019
Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancerT Boulding, R D McCuaig, A Tan, et al.
Scientific Reports|January 10, 2018
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancerT Boulding, R D McCuaig, A Tan, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2015
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17S Y Brulé, D J Jonker, C S Karapetis, et al.
Internal Medicine Journal|July 10, 2013
Developing a national database for metastatic colorectal cancer management: perspectives and challengesK Field, H-L Wong, J Shapiro, et al.
Scientific Reports|December 6, 2019
Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancerT Boulding, R D McCuaig, A Tan, et al.
Scientific Reports|January 10, 2018
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancerT Boulding, R D McCuaig, A Tan, et al.
Pageof 5